survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
Published 1 year ago • 238 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
0:53
prognostic trials for 21-gene oncotypedx in hr /her2- breast cancer with micrometastases
-
0:38
rxponder: 21-gene assay informs chemotherapy benefit in hr node-positive breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
3:10
genomic profiling of hr /her2- breast cancer and brain metastases
-
1:33
anti-müllerian hormone as a predictor of chemotherapy response in hr /her2- breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
1:26
rxponder: chemotherapy and endocrine therapy in hr /her2- breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
18:14
does 21-gene recurrence score assay testingchange decisions? dr. adher alsayed ( day 1)
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
1:41
adapt trial: endocrine ribociclib vs. chemotherapy in hr /her2- early breast cancer
-
5:54
roxane: impact of 21-gene assay on treatment for early breast cancer
-
0:57
enhertu - what it is and how it works #breastcancer
-
3:18
5-year outcomes from planb: phase 3 trial of 21-gene recurrence score® result in breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
46:25
the role of biomarkers in hr-positive/her2-negative early breast cancer: from clinical analysis t...